Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06396065
Title Phase III Study of AK112 for NSCLC Patients
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Summit Therapeutics
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | CAN

No variant requirements are available.